Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
D Dominion Energy Inc
GAIA Gaia Inc
ED Consolidated Edison Inc
RLJ RLJ Lodging Trust
CSCO Cisco Systems Inc
TFSA Terra Income Fund 6 LLC
JPM JPMorgan Chase & Co
NWSA News Corp
DUNE Dune Acquisition Corp
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Postmarket

Last Trade
Delayed
$175.55
-0.54 (-0.31%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$176.09
Day's Change
-1.24 (-0.70%)
Bid
--
Ask
--
B/A Size
--
Day's High
177.26
Day's Low
174.66
Volume
(Above Average)
Volume:
6,700,469

10-day average volume:
5,750,087
6,700,469

Company Profile

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Valuation Ratios

Price/Earnings (TTM)
24.69x
Price/Sales (TTM)
4.83x
Price/Book (MRQ)
6.22x
Price/Cash Flow (TTM)
17.70x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

November 2022
Current Month
12.7M
Previous Month
12.3M
Percent of Float
0.48%
Days to Cover
1.8141 Days

Share Information

JNJ is in a share class of common stock
Float
2.6B
Shares Outstanding
2.6B
Institutions Holding Shares
4,492
67.87%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Alex GorskyChmn.
  • Joaquin Boix DuatoCEO
  • Joseph J. WolkCFO
  • Peter M. Fasolo
  • James SwansonExec.VP

Address

  • One Johnson & Johnson Plaza
  • New Brunswick, NJ 08933
  • Phone: (732) 524-2455
  • Fax: (732) 214-0332
  • https://www.jnj.com/

Insider Trading

During the most recent quarter, 342K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.